您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > 2-D08
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
2-D08
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
2-D08图片
CAS NO:144707-18-6
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW) 270.24
Formula C15H10O5
CAS No. 144707-18-6
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO:>50 mg/mL
Water: < 1 mg/mL
Ethanol: < 1 mg/mL
Chemical Name 2-(2,3,4-trihydroxyphenyl)-4H-1-benzopyran-4-one
Synonyms 2-D08; 2 D08; 2D08.
SMILES Code O=C1C=C(C2=CC=C(O)C(O)=C2O)OC3=CC=CC=C13
实验参考方法
In Vitro

In vitro activity: 2-D08, a synthetic flavone, is a cell permeable inhibitor of protein sumoylation that has a unique mechanism of action. It is also inhibits Axl, IRAK4, ROS1, MLK4, GSK3β, RET, KDR and PI3Kα with IC50 values of 0.49, 3.9, 5.3, 9.8, 11, 11, 17 and 35 nM respectively in biochemical assays. Protein sumoylation is a dynamic posttranslational modification involved in diverse biological processes during cellular homeostasis and development. Sumoylation has been shown to play a critical role in cancer. 2-D08 showed anti-aggregatory and neuroprotective effect and may be used for the treatment of related diseases.


Kinase Assay: 2-D08 is a cell permeable, mechanistically unique inhibitor of protein sumoylation. It is also inhibits Axl, IRAK4, ROS1, MLK4, GSK3β, RET, KDR and PI3Kα with IC50 values of 0.49, 3.9, 5.3, 9.8, 11, 11, 17 and 35 nM respectively in biochemical assays. IC50 values of the Axl kinase inhibitor (2D08) are determined using kinase-mediated phosphorylation of poly-GAT by AlphaScreen luminescence detection technology. The inhibitor is tested at eight points of dilution in duplicate.


Cell Assay: Human lung multi-potent cells at passage 5 are plated at a density of 250 000 cells per well in six-well plates with growth medium. After 24 h, multi-potent cells are incubated with DMEM+0.5% BSA+penicillin/streptomycin containing 0.1% DMSO (vehicle) or 2D08 (0.1, 1, 10 μM) for 3 h in a humidified 5% CO2 incubator at 37℃. These cells are trypsinized and seeded at 20 000 cells per well in three replicates on 12-well cell culture transwell inserts with 8 μm pore size with DMEM+0.5% BSA+penicillin/streptomycin. Lower transwell chambers contained DMEM+10% FBS+penicillin/streptomycin are used to allow cells to migrate. 0.1% DMSO or 2D08 is added to corresponding upper and lower transwell chambers. After 16 h, non-migrated cells are removed by cotton swabs. Migrated cells are fixed with 4% PFA, permeabilized with methanol and stained with crystal violet. The field-images per transwell are taken by an inverted light microscope.

In VivoIn vivo injection of SUMO inhibitor 2-D08 into α2–/– and morphology analysis for gephyrin cluster colocalization with γ2 GABAARs; (right panel) quantification shows significant increase in gephyrin clustering along with γ2 GABAAR on the ipsi- compared with the contra-lateral hemisphere. Injection of SUMO pathway inhibitor 2-D08 (30 μM) or saline into α2–/– mice (n=3) on one hemisphere near the hippocampal area. Twenty-four hours after injection, we analysed for gephyrin and γ2 GABAAR clusters in both ipsi- and contralateral hemispheres. One could see inflammation using antibody against CD68, a marker for microglia, near the lesion caused by the 2-D08 injection, but not saline.
Animal model α2–/– mice (8 to 10 weeks old)
Formulation & Dosage Dissolved in 30 μM (10 μl); injected on one hemisphere near the hippocampal area
References Nat Commun. 2016 Nov 7;7:13365.